Page last updated: 2024-12-11

nidroxyzone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

nidroxyzone: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID9570072
CHEMBL ID92444
CHEBI ID134984
SCHEMBL ID467329
MeSH IDM0052613

Synonyms (46)

Synonym
nitrofuroxizone
CHEMBL92444
nitrofuroxizonum
5-nitro-2-furaldehyde,2-(2-hydroxyethyl)semicarbazone
nidroxyzone
furadroxyl r
f-26
nidroxyzon
2-furaldehyde, 2-(2-hydroxyethyl)semicarbazone
405-22-1
wln: t50j bnw e1unnvz2q
usaf ea-3
nsc6474
furadroxyl
nsc-6474
nf 67
furaxolon
furadroxyl r' nf67
hydrazinecarboxamide, 1-(2-hydroxyethyl)-2-[(5-nitro-2-furanyl)methylene]-
5-nitro-2-furaldehyde n'-(2-hydroxyethyl)semicarbazone
1-(2-hydroxyethyl)-1-[(e)-(5-nitro-2-furyl)methyleneamino]urea
5-nitro-2-furaldehyde 2-(2-hydroxyethyl)semicarbazone
2-furaldehyde, 5-nitro-, 2-(2-hydroxyethyl)semicarbazone
hydrazinecarboxamide, 1-(2-hydroxyethyl)-2-((5-nitro-2-furanyl)methylene)-
nf-67
nsc 6474
nidroxyzonum [inn-latin]
brn 0269535
ai3-26827
5-nitro-2-furaldehyde-2-(2-hydroxyethyl)semicarbazone
nidroxizona [inn-spanish]
nidroxyzone [inn]
2-(3-hydroxyethyl)-1-(5-nitrofurfuryliden)semicarbacid
einecs 206-970-3
f-26 (van)
CHEBI:134984
nidroxizona
yn9dmn3cvq ,
nidroxyzonum
unii-yn9dmn3cvq
4-17-00-04471 (beilstein handbook reference)
AKOS015901221
nidroxyzone [mi]
SCHEMBL467329
1-(2-hydroxyethyl)-1-[(e)-(5-nitrofuran-2-yl)methylideneamino]urea
1-(2-hydroxyethyl)-2-((5-nitrofuran-2-yl)methylene)hydrazinecarboxamide
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
furansCompounds containing at least one furan ring.
C-nitro compoundA nitro compound having the nitro group (-NO2) attached to a carbon atom.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID227700Anticonvulsant activity2003Bioorganic & medicinal chemistry letters, Aug-18, Volume: 13, Issue:16
Topological virtual screening: a way to find new anticonvulsant drugs from chemical diversity.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19906 (85.71)18.7374
1990's0 (0.00)18.2507
2000's1 (14.29)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]